Marc Wilson, CFO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 41,844 shares at $19.97 ($835K) on 2023-06-20, disclosed to the SEC on 2023-06-21.
Scheduled sale ($835k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.96 | 10,922 | $218K | 26.1% |
| 2 | $19.96 | 10,922 | $218K | 26.1% |
| 3 | $19.97 | 20,000 | $399K | 47.8% |
| Total | $19.96 avg | 41,844 | $835K | 100% |
| Filing → |
| CRNX | SELL | 2024-07-17 | $1.4M | — | Filing → |
| CRNX | SELL | 2024-07-02 | $2.8M | — | Filing → |
| CRNX | SELL | 2024-03-20 | $596K | — | Filing → |